Finance

Lists
300702:SHE
Zhejiang Tianyu Pharmaceutical Co Ltd
CNÂ¥20.89
-0.19%
(-0.040) 1D
Oct 16, 3:04:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300702...
Open
CNÂ¥21.21
High
CNÂ¥21.74
Low
CNÂ¥20.62
Mkt. cap
7.69B
Avg. vol.
2.84M
Volume
4.20M
Dividend
0.24%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
87.28
52-wk high
CNÂ¥27.80
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.24
Shares outstanding
347.98M
No. of employees
5K
Open
CNÂ¥21.21
High
CNÂ¥21.74
Low
CNÂ¥20.62
Mkt. cap
7.69B
Avg. vol.
2.84M
Volume
4.20M
Dividend
0.24%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 2, 2026
P/E ratio
87.28
52-wk high
CNÂ¥27.80
52-wk low
CNÂ¥17.98
EPS
CNÂ¥0.24
Shares outstanding
347.98M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Tianyu Pharmaceutical Co Ltd
CEO-
Employees4.69K
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitetianyupharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
719.55M
774.15M
811.67M
1.20B
Cost of goods sold
362.88M
604.51M
548.33M
880.22M
Cost of revenue
362.88M
604.51M
548.33M
880.22M
Research and development expenses
63.23M
60.66M
52.90M
71.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142.58M
207.09M
123.93M
149.32M
Operating expense
201.10M
283.89M
178.76M
242.96M
Total operating expenses
563.98M
888.40M
727.09M
1.12B
Operating income
155.57M
-114.24M
84.58M
75.89M
Other non operating income
3.16M
-8.84M
-12.56M
11.16M
EBT including unusual items
75.38M
-76.40M
46.43M
72.96M
EBT excluding unusual items
140.34M
-129.49M
63.99M
56.10M
Income tax expense
3.96M
4.82M
4.24M
10.54M
Effective tax rate
5.25%
-6.31%
9.13%
14.44%
Other operating expenses
4.28M
12.54M
2.51M
14.52M
Net income
71.42M
-81.22M
42.19M
61.72M
Net profit margin
9.93%
-10.49%
5.20%
5.15%
Earnings per share
-
-
-
-
Interest and investment income
807.20K
1.50M
1.45M
2.73M
Interest expense
-10.92M
-9.63M
-9.48M
-11.57M
Net interest expenses
-10.11M
-8.13M
-8.02M
-8.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
235.92M
-27.39M
171.43M
174.51M
Gain or loss from assets sale
-125.02K
434.71K
-
-1.29M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps